InvestorsHub Logo
Followers 87
Posts 6693
Boards Moderated 1
Alias Born 09/18/2009

Re: Preciouslife1 post# 40055

Wednesday, 07/26/2023 11:41:37 AM

Wednesday, July 26, 2023 11:41:37 AM

Post# of 42926
I can understand not being too happy.

But, one type of insolvency proceeding is a restructuring, which may include a merger.

https://www.chamberlain-co.co.uk/stages-of-insolvency/

I think this is clearly the path we are on. In evidence of that was our purchase of 500K shares of Baudax Bio on June 30th, which was when Baudax acquired TeraImmune. And TeraImmune also focuses on suppressing immune response, while Baudax has a small CDMO it is associated with. Good framework to build upon.

And no one has mentioned that Humanigen could very well own every share they have issued, which I think they do. I think we are poised to initiate a forward stock split with our merger, and cause a short squeeze.

As you noted, the company is "...exploring all restructuring options..." Why would we have funded Baudax's acquisition of TeraImmune, if we did not plan to merge with them?

Just my opinion, with just enough subtle substantiation for me to comfortably make that conclusion.